SMS Lifesciences India Limited
NSE:SMSLIFE.NS
1488.65 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,059.584 | 3,155.603 | 3,473.019 | 2,574.579 | 2,566.261 | 3,732.197 | 2,088.484 | 2,159.03 | 0 |
| Cost of Revenue
| 2,730.008 | 2,280.029 | 2,597.596 | 1,872.452 | 1,981.782 | 3,064.205 | 1,724.564 | 1,200.727 | 0 |
| Gross Profit
| 329.576 | 875.574 | 875.423 | 702.127 | 584.479 | 667.992 | 363.92 | 958.303 | 0 |
| Gross Profit Ratio
| 0.108 | 0.277 | 0.252 | 0.273 | 0.228 | 0.179 | 0.174 | 0.444 | 0 |
| Reseach & Development Expenses
| 0 | 34.785 | 28.749 | 19.549 | 11.387 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 32.401 | 26.874 | 31.13 | 21.752 | 15.487 | 12.882 | 7.35 | 0.019 |
| Selling & Marketing Expenses
| 0 | 22.124 | 23.407 | 20.987 | 17.814 | 33.123 | 20.431 | 25.517 | 0 |
| SG&A
| 167.823 | 54.525 | 50.281 | 52.117 | 39.566 | 48.61 | 33.313 | 32.866 | 0.019 |
| Other Expenses
| 38.281 | 30.725 | 2.548 | 4.154 | 6.394 | 3.381 | 5.735 | 17.236 | 0 |
| Operating Expenses
| 167.823 | 695.936 | 632.151 | 478.275 | 408.697 | 383.339 | 288.15 | 613.054 | 0.019 |
| Operating Income
| 161.753 | 180.47 | 246.539 | 223.852 | 175.782 | 284.654 | 75.77 | 226.045 | -0.019 |
| Operating Income Ratio
| 0.053 | 0.057 | 0.071 | 0.087 | 0.068 | 0.076 | 0.036 | 0.105 | 0 |
| Total Other Income Expenses Net
| -63.286 | -14.541 | 80.77 | -28.177 | -29.102 | -30.804 | -11.804 | -44.706 | 0 |
| Income Before Tax
| 98.467 | 165.929 | 327.309 | 195.675 | 146.68 | 253.849 | 63.966 | 181.339 | -0.019 |
| Income Before Tax Ratio
| 0.032 | 0.053 | 0.094 | 0.076 | 0.057 | 0.068 | 0.031 | 0.084 | 0 |
| Income Tax Expense
| 35.189 | 52.155 | 74.311 | 60.109 | 44.849 | 75.377 | -1.047 | 54.866 | -0.019 |
| Net Income
| 90.928 | 114.628 | 253.221 | 135.566 | 101.831 | 178.472 | 65.013 | 126.473 | -0.019 |
| Net Income Ratio
| 0.03 | 0.036 | 0.073 | 0.053 | 0.04 | 0.048 | 0.031 | 0.059 | 0 |
| EPS
| 30.08 | 37.92 | 83.76 | 44.84 | 33.68 | 59.03 | 21.5 | 42.81 | -0.006 |
| EPS Diluted
| 30.08 | 37.92 | 83.76 | 44.84 | 33.68 | 59.03 | 21.5 | 42.81 | -0.006 |
| EBITDA
| 311.129 | 318.248 | 356.58 | 315.744 | 270.385 | 361.46 | 152.495 | 287.837 | -0.019 |
| EBITDA Ratio
| 0.102 | 0.101 | 0.103 | 0.123 | 0.105 | 0.097 | 0.073 | 0.133 | 0 |